Wang Lingke sold $3.9M of LIFE

Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $33.29 ($32.63–$33.98, $3.94M total) across 3 trades on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang Lingke
Published Aug 21, 2026, 10:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The disclosed sale may lead to short‑term price weakness, but the pre‑arranged nature tempers significance.

02

Market read

Primary insider sale; modest materiality for a micro‑cap, limited broader market effect.

03

What to watch

Potential tax‑loss harvesting or portfolio rebalancing unrelated to company fundamentals.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑08‑20

Background

Form 4 filing discloses insider transactions; investors monitor these for signals.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

President Wang Lingke sold ~3.9M of LIFE shares via a 10b5‑1 plan on 2026‑08‑20.

Expected impact

Potential modest downside pressure over the next few days.

Evidence & confidence

Sale size (~$4M) is material for a micro‑cap; insider is a senior officer, suggesting possible information advantage.

Market effects

Minimal; limited to Ethos Technologies sector exposure.

None

None

Counterpoint

The sale could be routine under a pre‑arranged plan, not indicative of negative outlook.

Key entities

  • Ethos Technologies Inc.

    Issuer of ticker LIFE.

  • Wang Lingke

    President and director of Ethos Technologies.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEHighAI 8/10

Why is Ethos Technologies stock surging today?

Ethos Technologies (LIFE) stock rose 11.4% premarket after Q3 revenue of $235M beat estimates and guidance. Adjusted EBITDA was $35M, also topping forecasts. New policies increased 189% YoY. Citizens raised its price target to $55. Full-year 2026 revenue guidance increased to $838M-$842M.

$LIFEMed

Ethos Technologies Inc (LIFE) (Q3 2026) Earnings Call Highlights: Triple-Digit Revenue

Ethos Technologies (LIFE) reported Q3 2026 revenue of $235M, up 151% YoY, with adjusted EBITDA of $35M, exceeding guidance. Direct and third-party channel revenues grew 112% and 209% YoY, respectively. Contribution margin declined to 28%, and Q4 guidance implies growth deceleration to 102% YoY. Management discussed channel growth, carrier relationships, and margin dynamics during the earnings call.

$LIFEHigh

Ethos Reports Third Quarter Fiscal Year 2026 Financial Results

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Third Quarter Fiscal Year 2026 Financial Results • Q3 Revenue grew 151% year-over-year to $235 million • Q3 Direct Channel Revenue grew 112% year-over-year to $119 million • Q3 Third-Party Channel Revenue grew 209% year-over-year to $116 million Austin,